© Reuters. FILE PHOTO: General view outside GlaxoSmithKline (GSK) headquarters in Brentford, London, Britain, May 4, 2020. REUTERS/Matthew Childs
By Mrinmay Dey and Siddharth Cavale
(Reuters) -Consumer goods giant Unilever (NYSE:) said it had approached Glaxosmithkline (LON:) about buying the pharmaceutical group’s consumer goods arm, after a newspaper reported that a 50 billion-pound ($68.4 billion) bid it made had been rebuffed.
Unilever, which has been under fire from some investors for the group’s underperforming share price, confirmed the approach about a potential acquisition of the business in a statement on Saturday.
“GSK Consumer Healthcare is a leader in